p38 MAPK Recombinant Antbody Kit (KD-Validated)

Overview
Catalog #	bsm-90194r-50µL
Product Name	p38 MAPK Recombinant Antbody Kit (KD-Validated)
Applications	WB, FCM, IC
Specificity	Knockdown Validated
Reactivity	Human, Mouse, Rat
Specifications
Conjugation	Unconjugated
Host	Rabbit
Source	A synthesized peptide derived from human p38 MAPK
Immunogen Range	150-250/360
Clonality	Recombinant
Isotype	IgG
Concentration	Lot dependent
Purification	Affinity Purified
Storage Buffer	0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol
Storage Condition	-20 °C
Target
Gene ID	1432
Swiss Prot	Q16539
Synonyms	MAPK14; Mitogen-Activated Protein Kinase 14; PRKM14; PRKM15; CSBP1; CSBP2; CSPB1; P38; Mitogen-Activated Protein Kinase P38 Alpha; MAX-Interacting Protein; CSAID-Binding Protein; MAP Kinase P38 Alpha; P38 MAP Kinase; MAP Kinase 14; EC 2.7.11.24; SAPK2A; Mxi2; CSBP; MXI2; Cytokine Suppressive Anti-Inflammatory Drug Binding Protein; Cytokine Suppressive Anti-Inflammatory Drug-Binding Protein; P38 Mitogen Activated Protein Kinase; Stress-Activated Protein Kinase 2A; Stress-Activated Protein Kinase 2a; MAP Kinase Mxi2; MAP Kinase MXI2; P38alpha Exip; EC 2.7.11; P38ALPHA; MAPK 14; SAPK2a; EXIP; RK
Background	Cell Line: HT-1080 Knockdown technology: shRNA Knockdown
Application Dilution
WB	1:300-5000
FCM	1:20-100
IC	1:1000